Results for bronchial translation from English to Maltese

bronchial asthma
ażżma tal-bronki

bronchial carcinoma,
karċinoma fil-bronki,

bronchial breath sound
ħoss tan-nifs tal-bronki

hypersensitivity (e.g. bronchial hyperreactivity)
sensittività eċċessiva (eż. iperreattività tal-bronki)

children with pre-existing bronchial asthma
tfal b’ażżma tal-bronki eżistenti minn qabel

bronchial infections caused by pasteurella multocida.
Ħnieżer infezzjonijiet fil- bronki kkawżati minn pasteurella multocida

theophylline (used to improve bronchial air flow);
theophylline (jintuża biex itejjeb il-fluss tal-arja fil-bronki);

infections such as bronchial tube inflammation (bronchitis)
infezzjonijet bħal infjammazzjoni tat-tubu tal-bronki (bronkite)

bronchial hyper-reactivity, obstructive airways disorder
reattività eċċessiva tal-bronki, disturb ta’ ostruzzjoni tal- passaġġ tan-nifs

difficulty breathing (bronchial spasm) anaphylactic shock
diffikutà biex tieħu n-nifs (spażmu bronkjali) xokk anafilattik

bronchitol must also not be used in patients with bronchial hyperresponsiveness.
bronchitol lanqas ma jista’ jintuża f’pazjenti b’rispons eċċessiv tal-bronki.

tuberculosis of the lung parenchyma or the tracheo-bronchial tree.
it-tuberkolożi tal-parenċima tal-pulmun jew tas-siġra trakeo-bronkali.

patients who show bronchial hyperresponsiveness must not be treated with bronchitol.
il-pazjenti li juru rispons eċċessiv tal-bronki ma jistgħux jiġu ttrattati bi bronchitol.

bronchial hyperresponsiveness to inhaled mannitol (see section 4.4).
rispons eċċessiv tal-bronki għal mannitol li jittieħed man-nifs (ara sezzjoni 4.4).

bronchial infections caused by escherichia coli, salmonella spp. and pasteurella spp.
infezzjonijiet uroġenitali kkawżati minn escherichia coli

pecific medicines for the treatment of bronchial asthma (β-sympathomimetics)
mediċini speċifiċi għall-kura ta’ ażma fil-bronki (simpatomimetiċi-β)

common: asthma and related symptoms (such as wheezing and bronchial hyperactivity)
komuni: ażma u sintomi relatati (bħal tħarħir u attività eċċessiva tal-bronki)

bronchial hypersecretion, asthma attack in asthmatic patients or patients with a history of asthma, cough
iposekrezzjoni bronkjali, attakk tal-ażżma f’pazjenti ażżmatiċi jew pazjenti bi storja ta’ ażżma, sogħla

a dose of 90 micrograms administered during three hours in patients with acute bronchial obstruction raised no safety concerns.
doża ta’ 90 mikrogramma mogħtija matul tliet sigħat lil pazjenti b’ostruzzjoni akuta tal-bronki ma qajmet l-ebda tħassib dwar is-sigurtà.

reactive airway disease including bronchial asthma or a history of bronchial asthma, or severe chronic obstructive pulmonary disease.
marda reattiva tal-passaġġi tal-arja inkluż ażżma tal-bronki jew passat ta’ ażżma tal-bronki, jew marda severa kronika ostruttiva tal-pulmun.